+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Radiopharmaceuticals Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • Report
  • 100 Pages
  • September 2019
  • Region: Global
  • Infinium Global Research
  • ID: 4848146
UP TO OFF until Dec 31st 2022
The report on the global radiopharmaceuticals market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global radiopharmaceuticals market to grow with a CAGR of 8.5% over the forecast period from 2019-2025. The study on radiopharmaceuticals market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on radiopharmaceuticals market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global radiopharmaceuticals market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global radiopharmaceuticals market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers
  • Rapidly expanding rates of cancer and cardiovascular diseases
  • Growing public private partnerships in the healthcare infrastructure

2) Restraints
  • High cost of nuclear medicine

3) Opportunities
  • Growing focus on targeted therapies
  • Increasing number of potential radioisotopes in the pipeline

Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global radiopharmaceuticals market is segmented on the basis of radioisotopes, and end-users.

The Global Radiopharmaceuticals Market by Radioisotopes
  • Technetium-99
  • Thallium-201
  • Gallium-67
  • Iodine-123
  • Flourine-18
  • Rubidium-82
  • Yttrium-90
  • Lutetium-177
  • Other Radioisotopes

The Global Radiopharmaceuticals Market by End-users
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Research Centers

Company Profiles

The companies covered in the report include
  • GE Healthcare
  • Cardinal Health, Inc.
  • Mallinckrodt Pharmaceuticals
  • Lantheus Medical Imaging, Inc.
  • Bayer AG
  • Advanced Accelerator Applications S.A.
  • Bracco Imaging S.p.A.
  • Eczacibasi Monrol Nuclear Products Co.
  • Nordion Inc.
  • Urenco Group

What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the radiopharmaceuticals market.
2. Complete coverage of all the segments in the radiopharmaceuticals market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global radiopharmaceuticals market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Radiopharmaceuticals Market Highlights
2.2. Radiopharmaceuticals Market Projection
2.3. Radiopharmaceuticals Market Regional Highlights
3. Global Radiopharmaceuticals Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Radioisotopes
3.4.2. Growth Matrix Analysis by End-users
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Radiopharmaceuticals Market
4. Radiopharmaceuticals Market Macro Indicator Analysis
5. Global Radiopharmaceuticals Market by Radioisotopes
5.1. Technetium-99
5.2. Thallium-201
5.3. Gallium-67
5.4. Iodine-123
5.5. Flourine-18
5.6. Rubidium-82
5.7. Yttrium-90
5.8. Lutetium-177
5.9. Other Radioisotopes
6. Global Radiopharmaceuticals Market by End-users
6.1. Hospitals
6.2. Ambulatory Surgical Centers
6.3. Diagnostic Centers
6.4. Research Centers
7. Global Radiopharmaceuticals Market by Region 2019-2025
7.1. North America
7.1.1. North America Radiopharmaceuticals Market by Radioisotopes
7.1.2. North America Radiopharmaceuticals Market by End-users
7.1.3. North America Radiopharmaceuticals Market by Country
7.2. Europe
7.2.1. Europe Radiopharmaceuticals Market by Radioisotopes
7.2.2. Europe Radiopharmaceuticals Market by End-users
7.2.3. Europe Radiopharmaceuticals Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Radiopharmaceuticals Market by Radioisotopes
7.3.2. Asia-Pacific Radiopharmaceuticals Market by End-users
7.3.3. Asia-Pacific Radiopharmaceuticals Market by Country
7.4. RoW
7.4.1. RoW Radiopharmaceuticals Market by Radioisotopes
7.4.2. RoW Radiopharmaceuticals Market by End-users
7.4.3. RoW Radiopharmaceuticals Market by Sub-region
8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Radiopharmaceuticals Market
8.2. Companies Profiled
8.2.1. GE Healthcare
8.2.2. Cardinal Health, Inc.
8.2.3. Mallinckrodt Pharmaceuticals
8.2.4. Lantheus Medical Imaging, Inc.
8.2.5. Bayer AG
8.2.6. Advanced Accelerator Applications S.A.
8.2.7. Bracco Imaging S.p.A.
8.2.8. Eczacibasi Monrol Nuclear Products Co.
8.2.9. Nordion Inc.
8.2.10. Urenco Group
9. Appendix
9.1. Primary Research Findings and Questionnaire

Companies Mentioned

  • GE Healthcare
  • Cardinal Health, Inc.
  • Mallinckrodt Pharmaceuticals
  • Lantheus Medical Imaging, Inc.
  • Bayer AG
  • Advanced Accelerator Applications S.A.
  • Bracco Imaging S.p.A.
  • Eczacibasi Monrol Nuclear Products Co.
  • Nordion Inc.
  • Urenco Group